Showing results (321-330 of 355) with videos related to

Sort By:
Pageof 36
The Journal of Infectious Diseases|September 1, 2022
Identifying Paucisymptomatic or Asymptomatic and Unrecognized Ebola Virus Disease Among Close Contacts Based on Exposure Risk Assessments and Screening AlgorithmsDehkontee Gayedyu-Dennis, Mosoka P Fallah, Clara Drew, et al.
NPJ Vaccines|August 31, 2021
Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infectionKelly E Seaton, Rachel L Spreng, Milite Abraha, et al.
Science Immunology|October 29, 2021
Salmonella Typhi Vi capsule prime-boost vaccination induces convergent and functional antibody responsesLindsay C Dahora, Marije K Verheul, Katherine L Williams, et al.
Advanced Functional Materials|August 26, 2025
Precision-Engineered Cobalt-doped Iron Oxide Nanoparticles: From Octahedron Seeds to Cubical Bipyramids for Enhanced Magnetic HyperthermiaPrem Singh, Karthickraja Duraisamy, Constanze Raitmayr, et al.
Nature Medicine|June 27, 2025
A reference model of circulating hematopoietic stem cells across the lifespan with applications to diagnosticsN Furer, N Rappoport, O Milman, et al.
Ebiomedicine|August 20, 2015
Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccineeNathan I Nicely, Kevin Wiehe, Thomas B Kepler, et al.
Journal of Virology|November 29, 2023
Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variantsKan Li, Richard H C Huntwork, Gillian Q Horn, et al.
Frontiers in Immunology|March 6, 2023
A tool for evaluating heterogeneity in avidity of polyclonal antibodiesKan Li, Michael Dodds, Rachel L Spreng, et al.
ACS Nano|August 26, 2024
Lipid Nanoparticles Elicit Reactogenicity and Sickness Behavior in Mice Via Toll-Like Receptor 4 and Myeloid Differentiation Protein 88 AxisTetiana Korzun, Abraham S Moses, Antony Jozic, et al.
Frontiers in Immunology|January 10, 2022
Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus ControllersTinashe E Nyanhete, Robert J Edwards, Celia C LaBranche, et al.
Pageof 36